Duffy AG - Search Results

1

The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma.

Agdashian D, ElGindi M, Xie C, Sandhu M, Pratt D, Kleiner DE, Figg WD, Rytlewski JA, Sanders C, Yusko EC, Wood B, Venzon D, Brar G, Duffy AG, Greten TF, Korangy F. Agdashian D, et al. Among authors: duffy ag. Cancer Immunol Immunother. 2019 Apr;68(4):599-608. doi: 10.1007/s00262-019-02299-8. Epub 2019 Jan 28. Cancer Immunol Immunother. 2019. PMID: 30688989 Free PMC article.

2

Developing better treatments in hepatocellular carcinoma.

Duffy A, Greten T. Duffy A, et al. Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):551-60. doi: 10.1586/egh.10.58. Expert Rev Gastroenterol Hepatol. 2010. PMID: 20932140 Review.

3

S100A9 a new marker for monocytic human myeloid-derived suppressor cells.

Zhao F, Hoechst B, Duffy A, Gamrekelashvili J, Fioravanti S, Manns MP, Greten TF, Korangy F. Zhao F, et al. Immunology. 2012 Jun;136(2):176-83. doi: 10.1111/j.1365-2567.2012.03566.x. Immunology. 2012. PMID: 22304731 Free PMC article.

4

Locally advanced cancer of the esophagus, current treatment strategies, and future directions.

Rahma OE, Greten TF, Duffy A. Rahma OE, et al. Front Oncol. 2012 May 24;2:52. doi: 10.3389/fonc.2012.00052. eCollection 2012. Front Oncol. 2012. PMID: 22655277 Free PMC article.

5

Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study Group.

Duffy A, Rahma O, Greten TF. Duffy A, et al. Int J Cancer. 2013 Apr 1;132(7):1718. doi: 10.1002/ijc.27805. Epub 2012 Sep 18. Int J Cancer. 2013. PMID: 22930464 Free PMC article. No abstract available.

6

Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies.

Duffy A, Zhao F, Haile L, Gamrekelashvili J, Fioravanti S, Ma C, Kapanadze T, Compton K, Figg WD, Greten TF. Duffy A, et al. Cancer Immunol Immunother. 2013 Feb;62(2):299-307. doi: 10.1007/s00262-012-1332-3. Epub 2012 Aug 22. Cancer Immunol Immunother. 2013. PMID: 23011590 Free PMC article.

7

Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies.

Duffy A, Wilkerson J, Greten TF. Duffy A, et al. Hepatology. 2013 Mar;57(3):1068-77. doi: 10.1002/hep.26120. Epub 2013 Jan 18. Hepatology. 2013. PMID: 23112096 Free PMC article. Review.

8

Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials.

Rahma OE, Duffy A, Liewehr DJ, Steinberg SM, Greten TF. Rahma OE, et al. Ann Oncol. 2013 Aug;24(8):1972-9. doi: 10.1093/annonc/mdt166. Epub 2013 May 12. Ann Oncol. 2013. PMID: 23670093 Free PMC article. Review.

9

Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10.

Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF. Eggert T, et al. Gut. 2013 Nov;62(11):1667-8. doi: 10.1136/gutjnl-2013-305164. Epub 2013 May 25. Gut. 2013. PMID: 23708586 Free PMC article. No abstract available.

10

Personalized oncology in interventional radiology.

Abi-Jaoudeh N, Duffy AG, Greten TF, Kohn EC, Clark TW, Wood BJ. Abi-Jaoudeh N, et al. Among authors: duffy ag. J Vasc Interv Radiol. 2013 Aug;24(8):1083-92; quiz 1093. doi: 10.1016/j.jvir.2013.04.019. J Vasc Interv Radiol. 2013. PMID: 23885909 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page